News has learned that the Advanced Medical Solutions Group (AMS Group), which is valued at over £500 million, is being considered for acquisition by the private equity firm Inflexion.
It was unclear on Tuesday night if there were any ongoing discussions between the two parties, while sources close to both downplayed any hint of ongoing negotiations.
It’s also said that other private equity companies have been keeping an eye on AMS Group lately.
On Wednesday, AMS Group—the company behind surgical brands like LiquiBand and Resorba—is expected to release its half-year financial results.
Investors and analysts will probably ask it about whether or not it has recently discussed going private.
A flurry of offers for London-listed companies has revealed Inflexion’s interest; the most recent attempt concerned the automotive component manufacturer TI Fluid Systems.
AMS Group’s shares closed more than 4% higher on Tuesday at 241.5p.
Over the past 12 months, the stock has increased by almost a third.
Both AMS Group and Inflexion declined to comment.
